Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 26, 2019 - Issue 4
384
Views
7
CrossRef citations to date
0
Altmetric
Articles

Sjögren syndrome-related plasma cell disorder and multifocal nodular AL amyloidosis: clinical picture and pathological findings

, , , , , , & show all
Pages 225-233 | Received 12 Feb 2019, Accepted 01 Aug 2019, Published online: 18 Sep 2019

References

  • Merlini G, Dispenzieri A, Sanchorawala V. Systemic immunoglobulin light chain amyloidosis. Nat Rev Dis Primers. 2018;4(1):38.
  • Merlini G. CyBorD: stellar response rates in AL amyloidosis. Blood. 2012;119(19):4343–4345.
  • Paccalin M, Hachulla E, Cazalet C. Localized amyloidosis: a survey of 35 French cases. Amyloid. 2005;12(4):239–245.
  • Biewend ML, Menke DM, Calamia KT. The spectrum of localized amyloidosis: a case series of 20 patients and review of the literature. Amyloid. 2006;13(3):135–142.
  • Kourelis TV, Kyle RA, Dingli D, et al. Presentation and outcomes of localized immunoglobulin light chain amyloidosis: the Mayo Clinic experience. Mayo Clin Proc. 2017;92(6):908–917.
  • Katoh N, Matsuda M, Ikeda S. Clinical, endoscopic, and histopathological features of localized immunoglobulin light chain (AL) in the gastrointestinal tract. Amyloid. 2015;22(4):254–256.
  • Ikeda S. Localized amyloidogenic immunoglobulin light chain-derived amyloidosis in a young boy and an adolescent girl. Amyloid. 2017;24(2):138–140.
  • Asl KH, Liepniecks JJ, Nakamura M, et al. Organ-specific (localized) synthesis of Ig light chain amyloid. J Immunol. 1999;162:5556–5560.
  • Setoguchi M, Hoshii Y, Kawano H, et al. Analysis of plasma cell clonarity in localized AL amyloidosis. Amyloid. 2000;7(1):41–45.
  • Manthorpe R, Asmussen K, Oxholm P. Primary Sjögren syndrome: diagnostic criteria, clinical features, and disease activity. J Rheumatol. 1997;24:8–11.
  • Meijer JM, Schonland SO, Palladini G, et al. Sjögren's syndrome and localized nodular cutaneous amyloidosis: coincidence or a distinct clinical entity? Arthritis Rheum. 2008;58(7):1992–1999.
  • Kambouchner M, Godmer P, Guillevin L, et al. A low grade marginal zone B cell lymphoma of the breast associated with localized amyloidosis and corposa amylaceca in a woman with long standing primary Sjögren syndrome. J Clin Pathol. 2003;56(1):74–77.
  • Rajagopala S, Singh N, Gupta K, et al. Pulmonary amyloidosis in Sjögren syndrome: a case report and systemic review of the literature. Respirology. 2010;15(5):860–868.
  • Bardell A, Servitje O, Graells J, et al. Salivary gland lymphoplasmacytoid lymphoma with nodular cutaneous amyloid deposition and lambda chain paraproteinemia. Brit J Dermatol. 1996;135:329–329.
  • Jeong YJ, Lee KS, Chung MP, et al. Amyloidosis and lymphoproliferative disease in Sjögren syndrome. Thin-section computed tomography findings and histopathologic comparisons. J Comput Assist Tomogr. 2004;28(6):776–781.
  • Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554–558.
  • Hoshii Y, Setoguchi M, Iwata T, et al. Useful polyclonal antibodies against synthetic peptides corresponding to immunoglobulin light chain constant region for immunohistochemical detection of immunoglobulin light chain amyloidosis. Pathol Int. 2001;51(4):264–270.
  • Wechalekar AD, Schonland SO, Kastritis E, et al. A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis. Blood. 2013;121(17):3420–3427.
  • Schönland SO, Dreger P, de White T, et al. Current status of hematopoietic cell transplantation in the treatment of systemic amyloid light-chain amyloidosis. Bone Marrow Transplant. 2012;47(7):895–905.
  • Venner CP, Lane T, Foard D, et al. Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival. Blood. 2012;119(19):4387–4390.
  • Smith RRL, Hutchins GM, Moore GW, et al. Type and distribution of pulmonary parenchymal and vascular amyloid. Correlation with cardiac amyloidosis. Am J Med. 1979;66(1):96–104.
  • Cordier JF, Loire R, Brune J. Amyloidosis of the lower respiratory tract. Clinical and pathologic features in a series of 21 patients. Chest. 1986;90(6):827–831.
  • Gillmore JD, Hawkins PN. Amyloidosis and the respiratory tract. Thorax. 1999;54(5):444–451.
  • Ikeda S-I, Takabayashi Y, Maejima Y, et al. Nodular lung disease with five year survival and unilateral pleural effusion in AL amyloidosis. Amyloid. 1999;6 (4):292–296.
  • Yazaki M, Takei Y, Katoh M, et al. Postmortem findings in two familial amyloidosis patients with transthyretin variant Asp38Ala. Amyloid. 2000;7(4):270–277.
  • Ito I, Nagai S, Kitaichi M, et al. Pulmonary manifestations of primary Sjögren syndrome. A clinical, radiologic, and pathologic study. Am J Respir Crit Care Med. 2005;171(6):632–638.
  • Kobayashi H, Matsuoka R, Kitamura S, et al. Sjögren syndrome with multiple bullae and pulmonary nodular amyloidosis. Chest. 1988;94(2):438–440.
  • Schlegel J, Kienast K, Störkel S, et al. Primary pulmonary nodular amyloidosis and multiple emphysematous bullae in Sjögren syndrome. Pneumologie. 1992;46(12):634–637.
  • Lim JK, Lancy MQ, Kurtin PJ, et al. Pulmonary marginal zone lymphoma of MALT type as a cause of localized pulmonary amyloidosis. J Clin Pathol. 2001;54(8):642–646.
  • Wieker K, Röcken C, Koenigsmann M, et al. Pulmonary low-grade MALT-lymphoma associated with localized pulmonary amyloidosis. A case report. Amyloid. 2002;9(3):190–193.
  • Jones AW, Chatterji AN. Primary tracheobronchial amyloidosis within tracheobronchopathia osteoplastica. Br J Dis Chest. 1977;71:268–272.
  • Suzuki H, Matsui K, Hirashima T, et al. Three cases of the nodular pulmonary amyloidosis with a long-term observation. Intern Med. 2006;45(5):283–286.
  • Olsen KE, Sletten K, Sandgren O, et al. What is the role of giant cells in AL amyloidosis?. Amyloid. 1999;6(2):89–97.
  • Westermark P. Localized AL amyloidosis: a suicidal neoplasm. Ups J Med Sci. 2012;117(2):244–250.
  • Yoneyama K, Tochigi N, Oikawa A, et al. Primary localized cutaneous nodular amyloidosis in a patient with Sjögren syndrome: a review of the literature. J Dermatol. 2005;32(2):120–123.
  • Schwendiman MN, Beachkofsky TM, Wisco OJ, et al. Primary cutaneous nodular amyloidosis: case report and review of the literature. Cutis. 2009;84(2):87–92.
  • Wey S-J, Chen Y-M, Lai P-J, et al. Primary Sjögren syndrome manifested as localized cutaneous nodular amyloidosis. J Clin Rheumatol. 2011;17(7):368–370.
  • Ikeda S, Makishita H, Oguchi K, et al. Gastrointestinal amyloid deposition in familial amyloid polyneuropathy. Neurology. 1982;32(12):1364–1368.
  • Ikeda S, Yanagisawa N, Hongo M, et al. Vagus nerve and celiac ganglion lesions in generalized amyloidosis. A correlative study of familial amyloid polyneuropathy and AL-amyloidosis. J Neurol Sci. 1987;79(1–2):129–139.
  • Tokuda T, Takei Y, Takayama B, et al. Severe amyloid deposition in mammary glands of familial amyloid polyneuropathy. Amyloid. 2007;14(3):249–253.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.